National Research Corporation

NasdaqGS:NRC Stok Raporu

Piyasa değeri: US$426.3m

National Research Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

National Research's earnings have been declining at an average annual rate of -4.4%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 3.3% per year. National Research's return on equity is 78.2%, and it has net margins of 18.8%.

Anahtar bilgiler

-4.4%

Kazanç büyüme oranı

-3.6%

EPS büyüme oranı

Healthcare Sektör Büyümesi8.5%
Gelir büyüme oranı3.3%
Özkaynak getirisi78.2%
Net Marj18.8%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

Jun 19
National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

Jun 04
National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)

May 09
Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Feb 20
National Research's (NASDAQ:NRC) Dividend Will Be $0.12

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Dec 13
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Oct 01
Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Jul 10
We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Why We Like The Returns At National Research (NASDAQ:NRC)

May 04
Why We Like The Returns At National Research (NASDAQ:NRC)

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Mar 25
Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Nov 17
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corp: Market Is Discounting These Key Factors

Sep 18

National Research declares $0.24 dividend

Aug 23

National Research GAAP EPS of $0.33, revenue of $37.3M

Aug 02

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Jul 13
National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

May 27
Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research Corp.: Quality/Low Risk On Sale

May 17

The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

Mar 21
The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Feb 11
National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Gelir ve Gider Dağılımı

National Research nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:NRC Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2414427440
30 Jun 2414629450
31 Mar 2414730460
31 Dec 2314931470
30 Sep 2314929460
30 Jun 2314829450
31 Mar 2315030440
31 Dec 2215232430
30 Sep 2215235420
30 Jun 2215236410
31 Mar 2215137400
31 Dec 2114837390
30 Sep 2114436380
30 Jun 2114036360
31 Mar 2113535350
31 Dec 2013337340
30 Sep 2013138340
30 Jun 2013036350
31 Mar 2013036340
31 Dec 1912832330
30 Sep 1912631330
30 Jun 1912430320
31 Mar 1912031310
31 Dec 1812030310
30 Sep 1811929310
30 Jun 1811826320
31 Mar 1811824310
31 Dec 1711823300
30 Sep 1711622290
30 Jun 1711423270
31 Mar 1711221280
31 Dec 1610920280
30 Sep 1610721280
30 Jun 1610620280
31 Mar 1610419270
31 Dec 1510217270
30 Sep 1510116280
30 Jun 1510016270
31 Mar 159916260
31 Dec 149918250
30 Sep 149718240
30 Jun 149517250
31 Mar 149416250
31 Dec 139315250

Kaliteli Kazançlar: NRC has high quality earnings.

Büyüyen Kar Marjı: NRC's current net profit margins (18.8%) are lower than last year (19.3%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NRC's earnings have declined by 4.4% per year over the past 5 years.

Büyüme Hızlandırma: NRC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: NRC had negative earnings growth (-5.8%) over the past year, making it difficult to compare to the Healthcare industry average (11.4%).


Özkaynak Getirisi

Yüksek ROE: Whilst NRC's Return on Equity (78.22%) is outstanding, this metric is skewed due to their high level of debt.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin